Venezuela Approves Russia's Single-Dose Sputnik Light Vaccine, RDIF Says

© RIA Novosti . Russian Direct Investment Fund (RDIF) / Go to the photo bankIn this handout photo released by Russian Direct Investment Fund, a view shows a fridge with packages of Russian Sputnik-Light one-dose vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology during clinical trials, in Moscow, Russia.
In this handout photo released by Russian Direct Investment Fund, a view shows a fridge with packages of Russian Sputnik-Light one-dose vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology during clinical trials, in Moscow, Russia.  - Sputnik International, 1920, 15.05.2021
Subscribe
US
India
Global
MOSCOW (Sputnik) - The Venezuelan Health Ministry approved Russia's single-dose Sputnik Light vaccine against the coronavirus for use in the country, the Russian Direct Investment Fund (RDIF) said Saturday.

"The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian single-dose Sputnik Light vaccine against coronavirus by the Ministry of Health of the Bolivarian Republic of Venezuela," the RDIF said in a statement.

Sputnik Light is the first component of the Sputnik V vaccine, which was approved in Venezuela in January 2021 under the emergency use authorization.

"Sputnik Light demonstrated 79.4% efficacy according to analyzed data taken from 28 days after the injection was administered," the RDIF says.

Russia registered the single-dose Sputnik Light vaccine with 79.4% efficacy, developed as Sputnik V by the Gamaleya Research Institute, in May. It is efficient against all COVID-19 strains and has no registered complication cases after its administration.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала